Come up with a name for your new list and we'll add to it:
SAB Biotherapeutics raised a round of funding on August 28, 2018. Investors include
T. Denny Sanford.
SAB Biotherapeutics (SAB), headquartered in Sioux Falls, S.D. is a clinical stage, biopharmaceutical development company focused on the manufacturing of antibody therapeutics. SAB delivers a platform …